chr1-93184012-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001378204.1(CCDC18):āc.169A>Gā(p.Asn57Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000191 in 1,567,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001378204.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC18 | NM_001378204.1 | c.169A>G | p.Asn57Asp | missense_variant | 3/29 | ENST00000690025.1 | NP_001365133.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC18 | ENST00000690025.1 | c.169A>G | p.Asn57Asp | missense_variant | 3/29 | NM_001378204.1 | ENSP00000510597.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151892Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000422 AC: 1AN: 236968Hom.: 0 AF XY: 0.00000774 AC XY: 1AN XY: 129232
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1416020Hom.: 0 Cov.: 30 AF XY: 0.00000142 AC XY: 1AN XY: 703834
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151892Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74156
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.169A>G (p.N57D) alteration is located in exon 3 (coding exon 2) of the CCDC18 gene. This alteration results from a A to G substitution at nucleotide position 169, causing the asparagine (N) at amino acid position 57 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at